General Information of Drug (ID: DM7AFJ8)

Drug Name
Diannexin Drug Info
Indication
Disease Entry ICD 11 Status REF
Myocardial reperfusion injury NB31 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DM7AFJ8

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Annexin A5 (ANXA5) TT2Z83I ANXA5_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT00615966) Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients. U.S. National Institutes of Health.
2 Expression and purification of recombinant human annexin V in Escherichia coli. Prep Biochem Biotechnol. 2000 Nov;30(4):305-12.